Spectral AI Seeks Medicare Reimbursement Boost for Burn-Wound AI System
Event summary
- Spectral AI submitted a New Technology Add-On Payment (NTAP) application to CMS for its DeepView™ System on October 6, 2026.
- The DeepView System, granted FDA De Novo Classification in May 2026, uses AI and multispectral imaging to assess burn wound healing potential.
- NTAP approval could provide additional Medicare payments to hospitals, covering ~65% of the system's cost.
- CMS is expected to make a final determination by August 2027, with potential NTAP payments starting in October 2027.
The big picture
Spectral AI's NTAP application is a strategic move to address the financial burden of integrating innovative medical technologies into hospital workflows. The submission reflects broader industry trends where AI-driven diagnostic tools are seeking reimbursement models that align with their value proposition. Success could set a precedent for other medical device companies pursuing similar reimbursement pathways.
What we're watching
- Regulatory Approval
- Whether CMS will approve the NTAP application by August 2027, enabling additional Medicare payments for hospitals using the DeepView System.
- Adoption Barriers
- How NTAP approval could reduce adoption barriers for hospital systems and accelerate integration of the DeepView System into clinical workflows.
- Reimbursement Strategy
- The pace at which Spectral AI can secure additional reimbursement pathways to support its commercialization objectives.